organon is a dutch pharmaceutical company started in oss the netherlands. it is famous for "the pil" a birthcontrol pil. organon grew as a company and was taken over by schering plough and later on by merck and continues as msd in the netherlands. in the old days the compant was great, it used to be "gezellig" !
Company profile
Ticker
OGN
Exchange
Website
CEO
Kevin Ali
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Organon Algeria SARL • Organon Argentina S.R.L. • Organon Pharma Pty Ltd • Organon Austria GmbH • Organon Belgium BV • Organon Heist BV • Organon BH d.o.o. • Organon Farmacêutica Ltda. • Organon Canada Inc. • Organon Hong Kong Limited ...
IRS number
852269702
OGN stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
26 Feb 24
8-K
Results of Operations and Financial Condition
15 Feb 24
8-K
Departure of Directors or Certain Officers
5 Dec 23
10-Q
2023 Q3
Quarterly report
3 Nov 23
8-K
Results of Operations and Financial Condition
2 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
8-K
Results of Operations and Financial Condition
8 Aug 23
8-K
Entry into a Material Definitive Agreement
7 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
8 Jun 23
10-Q
2023 Q1
Quarterly report
4 May 23
Transcripts
OGN
Earnings call transcript
2023 Q4
15 Feb 24
OGN
Earnings call transcript
2023 Q3
2 Nov 23
OGN
Earnings call transcript
2023 Q2
8 Aug 23
OGN
Earnings call transcript
2023 Q1
4 May 23
OGN
Earnings call transcript
2022 Q4
16 Feb 23
OGN
Earnings call transcript
2022 Q3
3 Nov 22
OGN
Earnings call transcript
2022 Q2
4 Aug 22
OGN
Earnings call transcript
2022 Q1
5 May 22
OGN
Earnings call transcript
2021 Q4
17 Feb 22
OGN
Earnings call transcript
2021 Q3
11 Nov 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 414.00 mm | 414.00 mm | 414.00 mm | 414.00 mm | 414.00 mm | 414.00 mm |
Cash burn (monthly) | (no burn) | 7.08 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 48.24 mm | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 365.76 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 51.6 | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2023
76.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 703 |
Opened positions | 79 |
Closed positions | 66 |
Increased positions | 224 |
Reduced positions | 255 |
13F shares | Current |
---|---|
Total value | 3.40 tn |
Total shares | 195.87 mm |
Total puts | 4.43 mm |
Total calls | 1.27 mm |
Total put/call ratio | 3.5 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 31.43 mm | $545.63 bn |
BLK Blackrock | 15.72 mm | $272.92 bn |
STT State Street | 13.72 mm | $238.24 bn |
Mawer Investment Management | 12.85 mm | $223.04 bn |
IVZ Invesco | 10.24 mm | $177.78 bn |
Massachusetts Financial Services | 9.28 mm | $161.11 bn |
Geode Capital Management | 5.72 mm | $99.34 bn |
Lord, Abbett & Co. | 5.03 mm | $87.18 bn |
JHG Janus Henderson | 3.58 mm | $62.09 bn |
Sound Shore Management | 3.46 mm | $60.04 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar 24 | Kathryn DiMarco | Common Stock | Payment of exercise | Dispose F | No | No | 18.8 | 2,913 | 54.76 k | 20,150 |
31 Mar 24 | Kathryn DiMarco | Common Stock | Option exercise | Acquire M | No | No | 0 | 8,503 | 0.00 | 23,063 |
31 Mar 24 | Kathryn DiMarco | Common Stock | Payment of exercise | Dispose F | No | No | 18.8 | 1,471 | 27.65 k | 14,560 |
31 Mar 24 | Kathryn DiMarco | Common Stock | Option exercise | Acquire M | No | No | 0 | 4,294 | 0.00 | 16,031 |
31 Mar 24 | Kathryn DiMarco | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 8,503 | 0.00 | 17,007 |
31 Mar 24 | Kathryn DiMarco | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 4,294 | 0.00 | 4,294 |
31 Mar 24 | Kevin Ali | Common Stock | Payment of exercise | Dispose F | No | No | 18.8 | 21,553 | 405.20 k | 125,343 |
31 Mar 24 | Kevin Ali | Common Stock | Option exercise | Acquire M | No | No | 0 | 38,973 | 0.00 | 146,896 |
31 Mar 24 | Kevin Ali | Common Stock | Payment of exercise | Dispose F | No | No | 18.8 | 11,874 | 223.23 k | 107,923 |
31 Mar 24 | Kevin Ali | Common Stock | Option exercise | Acquire M | No | No | 0 | 21,471 | 0.00 | 119,797 |
News
Play Safe! S&P 500 is Teasingly Close to its 50 DMA: 3 Picks
12 Apr 24
Is WisdomTree U.S. High Yield Corporate Bond ETF (WFHY) a Strong ETF Right Now?
10 Apr 24
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
13 Mar 24
5 Value Stocks In The Healthcare Sector
4 Mar 24
New York Attorney General Urges FDA Action On Widely Used Asthma Drug's Concerns Over Pediatric Safety
26 Feb 24
Press releases
Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024
8 Apr 24
Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints
8 Apr 24
On International Women's Day, Organon Canada is encouraging businesses to Invest in HER and help address gender inequities through women's health
8 Mar 24
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2023
15 Feb 24
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 15, 2024
1 Feb 24